ArticleMolecular cancer therapeutics2018

Retraction: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.

Raju Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.